Alzheimer's Disease Diagnostic Global Market Report 2025

Description

Alzheimer's disease diagnostics involve methods and tools used to detect and confirm the presence of Alzheimer's, a progressive neurodegenerative disorder. These diagnostics include cognitive assessments, imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, and biomarker tests that analyze cerebrospinal fluid (CSF) or blood for amyloid-beta and tau proteins.

The primary types of Alzheimer's disease diagnostics include triage, diagnosis, and screening. Triage is a systematic method for prioritizing patients based on the urgency and severity of their cognitive symptoms. Diagnostic techniques encompass biomarkers, imaging techniques, genetic testing, and cognitive assessment tests. These are utilized by various end users, including clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers.

The alzheimer's disease diagnostic market research report is one of a series of new reports from The Business Research Company that provides alzheimer's disease diagnostic market statistics, including alzheimer's disease diagnostic industry global market size, regional shares, competitors with a alzheimer's disease diagnostic market share, detailed alzheimer's disease diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the alzheimer's disease diagnostic industry. This alzheimer's disease diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alzheimer's disease diagnostic market size has grown rapidly in recent years. It will grow from $6.56 billion in 2024 to $7.28 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth during the historic period can be attributed to the rising prevalence of Alzheimer's disease and dementia, increasing awareness of the importance of early diagnosis for better management, advancements in imaging technologies such as MRI and PET scans, growing investment in research and development for neurodegenerative diseases, and government initiatives and funding for Alzheimer's research and diagnostics.

The alzheimer's disease diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the development of blood-based biomarkers for non-invasive diagnosis, increasing demand for personalized medicine and precision diagnostics, the integration of AI and machine learning in diagnostic tools for early detection, the growing adoption of digital health technologies for remote monitoring and diagnosis, and the expansion of healthcare infrastructure in emerging markets to improve accessibility. Key trends expected during this period include the emergence of multi-modal diagnostic approaches combining imaging, biomarkers, and cognitive tests, a rising focus on point-of-care diagnostic solutions for faster results, the development of wearable devices for continuous monitoring of cognitive health, increased collaborations between biotech companies and research institutions for innovative solutions, and the growth of direct-to-consumer genetic testing for Alzheimer's risk assessment.

The rise in chronic diseases is anticipated to drive the growth of the Alzheimer's disease diagnostic market. Chronic disease refers to a long-term health condition that persists for more than three months. The increasing prevalence of chronic diseases is influenced by several interconnected factors, including lifestyle choices, environmental factors, genetic predisposition, and socioeconomic conditions. The presence of chronic conditions such as cardiovascular issues, diabetes, and hypertension elevates the risk of developing Alzheimer's disease (AD) and other forms of dementia. For example, in January 2022, a report by the American Heart Association Inc., a US-based nonprofit voluntary organization, stated that brain disorders in the US are expected to increase to 9.3 million by 2060, with the number currently growing. Additionally, one in every six people worldwide suffers from a brain disease, and by 2021, approximately 1 billion people globally were affected by brain disorders. As a result, the increasing prevalence of chronic diseases is expected to drive the growth of the Alzheimer's disease diagnostic market.

Leading companies in the Alzheimer's disease diagnostic market are prioritizing advancements in blood-based biomarker tests, which are expected to streamline the diagnostic process for Alzheimer's disease. These advancements aim to reduce dependence on more invasive procedures and enhance access to timely treatment for patients. For example, in October 2023, Quanterix, a US-based biotechnology research company, introduced the LucentAD p-Tau 217 test, a biomarker for Alzheimer's pathology that offers high clinical sensitivity and specificity in blood testing. Traditional methods for cerebrospinal fluid (CSF) biomarker analysis involve positron emission tomography (PET) scans or lumbar punctures, both of which are costly, invasive, and not widely accessible. The new test integrates Quanterix's ultra-sensitive SimoaO technology with J&J Innovative Medicine's extensively tested p-Tau 217 antibodies, ensuring high accuracy and a more straightforward diagnostic process.

In July 2024, Lantheus, a US-based radiopharmaceutical company, acquired Meilleur Technologies for an undisclosed amount. This acquisition is aimed at expanding Lantheus' portfolio of PET imaging agents for Alzheimer's disease. Meilleur Technologies, a US-based biopharmaceutical company, has collaborated with research institutions to develop imaging biomarkers for Alzheimer's disease.

Major players in the alzheimer's disease diagnostic market are Pfizer Inc., AbbVie, Bristol Myers Squibb Company, Hoffmann-La Roche, Eli Lilly and Company, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Daiichi Sankyo Co., Sysmex, Lantheus, Quanterix, FujireBio, TauRx Pharmaceuticals Ltd, AC Immune, C2N diagnostics, AXON Neuroscience, Neuro-Bio Ltd, Anavex Life Sciences Corp., and Treventis Corporation.

North America was the largest region in the alzheimer's disease diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alzheimer's disease diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alzheimer's disease diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alzheimer's disease diagnostic market consists of revenues earned by entities by providing services such as cognitive assessment tests, genetic tests, biomarker tests, and cerebrospinal fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The alzheimer's disease diagnostic market also includes sales of genetic testing kits, cognitive assessment tools, imaging equipment, biomarker kits, and wearable devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alzheimer's Disease Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alzheimer's disease diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alzheimer's disease diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alzheimer's disease diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Triage; Diagnosis; Screening
2) By Diagnostic Technique: Biomarkers; Imaging Techniques; Genetic Testing; Cognitive Assessment Tests
3) By End User: Clinics; Hospitals; Diagnostic Centers; Pharmaceutical Companies; Academic Research Center
Subsegments:
1) By Triage: Cognitive Testing; Imaging Techniques
2) By Diagnosis: Biomarker Testing; Neuroimaging
3) By Screening: Neuropsychological Testing; Genetic Testing
Companies Mentioned: Pfizer Inc.; AbbVie; Bristol Myers Squibb Company; Hoffmann-La Roche; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33959

1. Executive Summary

2. Alzheimer's Disease Diagnostic Market Characteristics

3. Alzheimer's Disease Diagnostic Market Trends And Strategies

4. Alzheimer's Disease Diagnostic Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Alzheimer's Disease Diagnostic Growth Analysis And Strategic Analysis Framework

5.1. Global Alzheimer's Disease Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Alzheimer's Disease Diagnostic Market Growth Rate Analysis
5.4. Global Alzheimer's Disease Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Alzheimer's Disease Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Alzheimer's Disease Diagnostic Total Addressable Market (TAM)

6. Alzheimer's Disease Diagnostic Market Segmentation

6.1. Global Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triage
Diagnosis
Screening
6.2. Global Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biomarkers
Imaging Techniques
Genetic Testing
Cognitive Assessment Tests
6.3. Global Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Hospitals
Diagnostic Centers
Pharmaceutical Companies
Academic Research Center
6.4. Global Alzheimer's Disease Diagnostic Market, Sub-Segmentation Of Triage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cognitive Testing
Imaging Techniques
6.5. Global Alzheimer's Disease Diagnostic Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biomarker Testing
Neuroimaging
6.6. Global Alzheimer's Disease Diagnostic Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuropsychological Testing
Genetic Testing

7. Alzheimer's Disease Diagnostic Market Regional And Country Analysis

7.1. Global Alzheimer's Disease Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Alzheimer's Disease Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alzheimer's Disease Diagnostic Market

8.1. Asia-Pacific Alzheimer's Disease Diagnostic Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alzheimer's Disease Diagnostic Market

9.1. China Alzheimer's Disease Diagnostic Market Overview
9.2. China Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alzheimer's Disease Diagnostic Market

10.1. India Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alzheimer's Disease Diagnostic Market

11.1. Japan Alzheimer's Disease Diagnostic Market Overview
11.2. Japan Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alzheimer's Disease Diagnostic Market

12.1. Australia Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alzheimer's Disease Diagnostic Market

13.1. Indonesia Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alzheimer's Disease Diagnostic Market

14.1. South Korea Alzheimer's Disease Diagnostic Market Overview
14.2. South Korea Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alzheimer's Disease Diagnostic Market

15.1. Western Europe Alzheimer's Disease Diagnostic Market Overview
15.2. Western Europe Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alzheimer's Disease Diagnostic Market

16.1. UK Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alzheimer's Disease Diagnostic Market

17.1. Germany Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alzheimer's Disease Diagnostic Market

18.1. France Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alzheimer's Disease Diagnostic Market

19.1. Italy Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alzheimer's Disease Diagnostic Market

20.1. Spain Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alzheimer's Disease Diagnostic Market

21.1. Eastern Europe Alzheimer's Disease Diagnostic Market Overview
21.2. Eastern Europe Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alzheimer's Disease Diagnostic Market

22.1. Russia Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alzheimer's Disease Diagnostic Market

23.1. North America Alzheimer's Disease Diagnostic Market Overview
23.2. North America Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alzheimer's Disease Diagnostic Market

24.1. USA Alzheimer's Disease Diagnostic Market Overview
24.2. USA Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alzheimer's Disease Diagnostic Market

25.1. Canada Alzheimer's Disease Diagnostic Market Overview
25.2. Canada Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alzheimer's Disease Diagnostic Market

26.1. South America Alzheimer's Disease Diagnostic Market Overview
26.2. South America Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alzheimer's Disease Diagnostic Market

27.1. Brazil Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alzheimer's Disease Diagnostic Market

28.1. Middle East Alzheimer's Disease Diagnostic Market Overview
28.2. Middle East Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alzheimer's Disease Diagnostic Market

29.1. Africa Alzheimer's Disease Diagnostic Market Overview
29.2. Africa Alzheimer's Disease Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Alzheimer's Disease Diagnostic Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Alzheimer's Disease Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alzheimer's Disease Diagnostic Market Competitive Landscape And Company Profiles

30.1. Alzheimer's Disease Diagnostic Market Competitive Landscape
30.2. Alzheimer's Disease Diagnostic Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Alzheimer's Disease Diagnostic Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG
31.2. Laboratory Corporation of America Holdings
31.3. Quest Diagnostics Incorporated
31.4. Daiichi Sankyo Co.
31.5. Sysmex
31.6. Lantheus
31.7. Quanterix
31.8. FujireBio
31.9. TauRx Pharmaceuticals Ltd
31.10. AC Immune
31.11. C2N diagnostics
31.12. AXON Neuroscience
31.13. Neuro-Bio Ltd
31.14. Anavex Life Sciences Corp.
31.15. Treventis Corporation

32. Global Alzheimer's Disease Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alzheimer's Disease Diagnostic Market

34. Recent Developments In The Alzheimer's Disease Diagnostic Market

35. Alzheimer's Disease Diagnostic Market High Potential Countries, Segments and Strategies

35.1 Alzheimer's Disease Diagnostic Market In 2029 - Countries Offering Most New Opportunities
35.2 Alzheimer's Disease Diagnostic Market In 2029 - Segments Offering Most New Opportunities
35.3 Alzheimer's Disease Diagnostic Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer